Free tool
Medicare drug spending
Last checked: Nov 19, 2026Latest source record: 2024 calendar yearSource: CMS (Medicare Part D Spending by Drug : 2024-01-01; Medicare Part B Spending by Drug : 2024-01-01)Methods & limitations
Part D, 2024
$288.7B
Gross drug spending in the dataset
Part B, 2024
$60.8B
Gross drug spending in the dataset
Drugs listed
5
Part D and Part B
Total spending by year
- Part D
- Part B
View as table
| Year | Part D | Part B |
|---|---|---|
| 2020 | $194,092,038,339 | $37,778,829,680 |
| 2021 | $213,513,349,361 | $40,135,340,775 |
| 2022 | $239,779,215,689 | $44,241,259,745 |
| 2023 | $275,808,918,753 | $50,775,853,083 |
| 2024 | $288,667,842,058 | $60,838,164,403 |
Top 5 by total spending
2024 figures. Growth compares with 2023. Per-beneficiary ranks skip drugs with fewer than 11 beneficiaries.
| Drug | Part | Spending | Change | Beneficiaries | Per beneficiary | Per unit |
|---|---|---|---|---|---|---|
| Meropenem Meropenem | D | $17.5M | -12% | 30,252 | $578 | $4.31 |
| Meropenem-0.9% NaCl Meropenem-0.9% Sodium Chloride | D | $3.0M | +27% | 3,669 | $805 | $29.51 |
| Vabomere Meropenem/Vaborbactam | D | $1.1M | -28% | 100 | $11,257 | $46.26 |
| Meropenem* Meropenem* · J2185 | B | $108K | -33% | 997 | $108 | $0.39 |
| Meropenem-0.9% NaCl Meropenem-0.9% Sodium Chloride · J2184 | B | $6K | n/a | 155 | $39 | $2.04 |
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.